MG
CVS icon

Michael Gelband’s CVS Health CVS Stock Holding History

Michael Gelband’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
11,616
-127,074
-92% -$11.3M 0.01% 1013
2026
Q1 		$9.96M Buy
138,690
+4,843
+4% +$373K 0.08% 235
2025
Q4 		$10.6M Buy
+133,847
New +$10.6M 0.08% 244
2025
Q3 		– Sell
-129,332
Closed -$8.92M – 1630
2025
Q2 		$8.92M Sell
129,332
-71,865
-36% -$4.71M 0.08% 262
2025
Q1 		$13.6M Sell
201,197
-53,579
-21% -$3.21M 0.13% 152
2024
Q4 		$11.4M Buy
+254,776
New +$14.3M 0.08% 241
2024
Q1 		– Sell
-153,242
Closed -$12.1M – 1578
2023
Q4 		$12.1M Sell
153,242
-129,065
-46% -$9.19M 0.08% 177
2023
Q3 		$19.7M Buy
282,307
+221,704
+366% +$15.7M 0.19% 100
2023
Q2 		$4.19M Sell
60,603
-69,499
-53% -$4.95M 0.03% 523
2023
Q1 		$9.67M Sell
130,102
-137,155
-51% -$11.5M 0.08% 285
2022
Q4 		$24.9M Buy
267,257
+235,597
+744% +$22.7M 0.36% 50
2022
Q3 		$3.02M Sell
31,660
-56,814
-64% -$5.62M 0.04% 592
2022
Q2 		$8.2M Sell
88,474
-50,615
-36% -$4.94M 0.1% 238
2022
Q1 		$14.1M Buy
139,089
+71,106
+105% +$7.47M 0.18% 116
2021
Q4 		$7.01M Buy
+67,983
New +$6.28M 0.07% 321
2021
Q3 		– Sell
-13,841
Closed -$1.16M – 2204
2021
Q2 		$1.16M Sell
13,841
-24,478
-64% -$2M 0.01% 931
2021
Q1 		$2.88M Sell
38,319
-8,618
-18% -$628K 0.04% 436
2020
Q4 		$3.21M Buy
46,937
+10,944
+30% +$712K 0.03% 378
2020
Q3 		$2.1M Buy
35,993
+11,540
+47% +$718K 0.04% 384
2020
Q2 		$1.59M Buy
24,453
+3,682
+18% +$232K 0.04% 521
2020
Q1 		$1.23M Sell
20,771
-7,032
-25% -$469K 0.07% 264
2019
Q4 		$2.06M Buy
+27,803
New +$1.95M 0.04% 335
2019
Q3 		– Sell
-58,219
Closed -$3.17M – 1385
2019
Q2 		$3.17M Buy
+58,219
New +$3.14M 0.13% 109
2019
Q1 		– Sell
-24,022
Closed -$1.57M – 688
2018
Q4 		$1.57M Buy
+24,022
New +$1.79M 0.11% 64

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Michael Gelband's CVS Position: Q2 2026 in Review

Michael Gelband reduced its CVS Health (CVS) stake by 92% in Q2 2026, selling an estimated $11.3M and leaving 11,616 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1013.

Michael Gelband first reported a position in CVS in Q4 2018 and has held it in 24 quarters since. The position peaked at $24.9M in Q4 2022. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Michael Gelband held 11,616 shares of CVS Health worth $1.2M as of Q2 2026.
  • Michael Gelband sold 127,074 CVS Health shares in Q2 2026, an estimated $11.3M.
  • CVS Health made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1013 holding.
  • Michael Gelband first reported a position in CVS Health in Q4 2018 and has held it in 24 quarters since.
  • Michael Gelband's CVS Health position peaked at $24.9M in Q4 2022.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.